Hsbc Holdings PLC Ultragenyx Pharmaceutical Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 16,100 shares of RARE stock, worth $730,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,100
Holding current value
$730,940
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$40.21 - $59.36 $647,381 - $955,696
16,100 New
16,100 $894,000
Q1 2024

May 15, 2024
SELL
$43.02 - $53.69 $90,944 - $113,500
-2,114 Reduced 10.86%
17,349 $810,000
Q4 2023

Feb 12, 2024
SELL
$31.73 - $49.19 $238,355 - $369,515
-7,512 Reduced 27.85%
19,463 $930,000
Q3 2023

Nov 13, 2023
BUY
$34.92 - $46.66 $92,957 - $124,208
2,662 Added 10.95%
26,975 $961,000
Q2 2023

Aug 11, 2023
SELL
$37.35 - $52.15 $100,807 - $140,752
-2,699 Reduced 9.99%
24,313 $1.12 Million
Q1 2023

May 15, 2023
SELL
$36.99 - $48.71 $1.68 Million - $2.21 Million
-45,468 Reduced 62.73%
27,012 $1.08 Million
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $2.08 Million - $2.86 Million
61,631 Added 568.08%
72,480 $3.36 Million
Q3 2022

Nov 14, 2022
SELL
$39.96 - $66.14 $115,244 - $190,747
-2,884 Reduced 21.0%
10,849 $457,000
Q2 2022

Aug 11, 2022
SELL
$45.8 - $85.4 $42,823 - $79,849
-935 Reduced 6.37%
13,733 $810,000
Q1 2022

May 16, 2022
BUY
$62.2 - $84.4 $511,968 - $694,696
8,231 Added 127.87%
14,668 $1.07 Million
Q4 2021

Feb 11, 2022
SELL
$73.71 - $87.86 $29,262 - $34,880
-397 Reduced 5.81%
6,437 $541,000
Q3 2021

Nov 12, 2021
SELL
$77.92 - $102.4 $143,216 - $188,211
-1,838 Reduced 21.19%
6,834 $611,000
Q2 2021

Aug 13, 2021
BUY
$92.19 - $115.71 $411,443 - $516,413
4,463 Added 106.03%
8,672 $826,000
Q1 2021

May 14, 2021
SELL
$106.9 - $167.73 $614,995 - $964,950
-5,753 Reduced 57.75%
4,209 $479,000
Q4 2020

Feb 12, 2021
BUY
$84.4 - $177.39 $396,595 - $833,555
4,699 Added 89.28%
9,962 $1.38 Million
Q3 2020

Nov 12, 2020
BUY
$72.98 - $90.0 $384,093 - $473,670
5,263 New
5,263 $445,000
Q1 2020

May 15, 2020
SELL
$33.8 - $62.9 $859,331 - $1.6 Million
-25,424 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$36.08 - $45.83 $109,105 - $138,589
-3,024 Reduced 10.63%
25,424 $1.1 Million
Q3 2019

Nov 14, 2019
BUY
$42.5 - $63.11 $1.21 Million - $1.8 Million
28,448 New
28,448 $1.22 Million
Q2 2018

Aug 10, 2018
SELL
$48.54 - $85.31 $202,266 - $355,486
-4,167 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$44.33 - $58.52 $184,723 - $243,852
4,167 New
4,167 $213,000

Others Institutions Holding RARE

# of Institutions
326
Shares Held
85.7M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.18B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email